With the MAHA movement poised to introduce a lot more "integrative" or "complementary and alternative" treatments into oncology (and medicine in general), a new study shows the likely result.

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

That superhero is a gene called TP53, and for decades scientists have known it as the “guardian of the genome.” In a healthy cell, TP53 acts like both a brake and an emergency stop button. When DNA ...

Two new studies from investigators at Mass General Brigham challenge a decades-old assumption that the thymus, an organ best ...

Share on Pinterest The novel AI-ready database could help to accelerate cancer immunotherapy research. Image credit: Assembly/Getty Images The Cancer Research Institute (CRI) launches a ...

“How can I deliver care not just to the 100,000 patients who might have cancer but to the 500,000 patients who may be at risk of cancer?” That question is shaping the early tenure of Anirban Maitra, ...

For decades, cancer care remained relatively unchanged, as doctors largely relied on three main strategies for confronting tumors: surgery, radiation, and chemotherapy. Yes, more sophisticated ...

Puzzling cancer and Alzheimer's link explored in new study: 'SHORT QUOTE' A new study may help clarify a long-observed link between cancer history and reduced Alzheimer’s risk. The research, published ...

Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve ...